Targeting membrane contact sites to mediate lipid dynamics: innovative cancer therapies
Guardat en:
| Publicat a: | Cell Communication and Signaling vol. 23 (2025), p. 1 |
|---|---|
| Autor principal: | |
| Altres autors: | , , , , , , , , , , , |
| Publicat: |
Springer Nature B.V.
|
| Matèries: | |
| Accés en línia: | Citation/Abstract Full Text Full Text - PDF |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3201566405 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 1478-811X | ||
| 024 | 7 | |a 10.1186/s12964-025-02089-z |2 doi | |
| 035 | |a 3201566405 | ||
| 045 | 2 | |b d20250101 |b d20251231 | |
| 084 | |a 67199 |2 nlm | ||
| 100 | 1 | |a Wang, Jie | |
| 245 | 1 | |a Targeting membrane contact sites to mediate lipid dynamics: innovative cancer therapies | |
| 260 | |b Springer Nature B.V. |c 2025 | ||
| 513 | |a Journal Article | ||
| 520 | 3 | |a Membrane contact sites (MCS) are specialized regions where organelles are closely interconnected through membrane structures, facilitating the transfer and exchange of ions, lipids, and other molecules. This proximity enables a synergistic regulation of cellular homeostasis and functions. The formation and maintenance of these contact sites are governed by specific proteins that bring organelle membranes into close apposition, thereby enabling functional crosstalk between cellular compartments. In eukaryotic cells, lipids are primarily synthesized and metabolized within distinct organelles and must be transported through MCS to ensure proper cellular function. Consequently, MCS act as pivotal platforms for lipid synthesis and trafficking, particularly in cancer cells and immune cells within the tumor microenvironment, where dynamic alterations are critical for maintaining lipid homeostasis. This article provides a comprehensive analysis of how these cells exploit membrane contact sites to modulate lipid synthesis, metabolism, and transport, with a specific focus on how MCS-mediated lipid dynamics influence tumor progression. We also examine the differences in MCS and associated molecules across various cancer types, exploring novel therapeutic strategies targeting MCS-related lipid metabolism for the development of anticancer drugs, while also addressing the challenges involved. | |
| 653 | |a Cancer | ||
| 653 | |a Membranes | ||
| 653 | |a Signal transduction | ||
| 653 | |a Organelles | ||
| 653 | |a Homeostasis | ||
| 653 | |a Apposition | ||
| 653 | |a Adipocytes | ||
| 653 | |a Antineoplastic drugs | ||
| 653 | |a Obesity | ||
| 653 | |a Fatty acids | ||
| 653 | |a Electron microscopes | ||
| 653 | |a Lipid metabolism | ||
| 653 | |a Phase transitions | ||
| 653 | |a Tumor microenvironment | ||
| 653 | |a Tumors | ||
| 653 | |a Immunosuppressive agents | ||
| 653 | |a Metabolism | ||
| 653 | |a Lipids | ||
| 653 | |a Drug development | ||
| 653 | |a Metabolites | ||
| 653 | |a Morphology | ||
| 653 | |a Cancer therapies | ||
| 653 | |a Proteins | ||
| 700 | 1 | |a Wang, Meifeng | |
| 700 | 1 | |a Zeng, Xueni | |
| 700 | 1 | |a Li, Yanhan | |
| 700 | 1 | |a Lei, Lingzhi | |
| 700 | 1 | |a Chen, Changan | |
| 700 | 1 | |a Lin, Xi | |
| 700 | 1 | |a Fang, Peiyuan | |
| 700 | 1 | |a Guo, Yuxuan | |
| 700 | 1 | |a Jiang, Xianjie | |
| 700 | 1 | |a Wang, Yian | |
| 700 | 1 | |a Chen, Lihong | |
| 700 | 1 | |a Long, Jun | |
| 773 | 0 | |t Cell Communication and Signaling |g vol. 23 (2025), p. 1 | |
| 786 | 0 | |d ProQuest |t Health & Medical Collection | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3201566405/abstract/embedded/75I98GEZK8WCJMPQ?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text |u https://www.proquest.com/docview/3201566405/fulltext/embedded/75I98GEZK8WCJMPQ?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/3201566405/fulltextPDF/embedded/75I98GEZK8WCJMPQ?source=fedsrch |